Expression of Siglec-8 is regulated by interleukin-5, and serum levels of soluble Siglec-8 may predict responsiveness of severe eosinophilic asthma to mepolizumab

Sayaka Arakawa; Maho Suzukawa; Nobuharu Ohshima; Hiroyuki Tashimo; Isao Asari; Hirotoshi Matsui; Nobuyuki Kobayashi; Shunsuke Shoji; Takahide Nagase; Ken Ohta

doi:10.1016/j.alit.2018.03.006

LETTERS TO THE EDITOR

Expression of Siglec-8 is regulated by interleukin-5, and serum levels of soluble Siglec-8 may predict responsiveness of severe eosinophilic asthma to mepolizumab

Sayaka Arakawa, Maho Suzukawa, Nobuharu Ohshima, Hiroyuki Tashimo, Isao Asari, Hirotoshi Matsui, Nobuyuki Kobayashi, Shunsuke Shoji, Takahide Nagase, Ken Ohta

Author information

Sayaka Arakawa
National Hospital Organization, Tokyo National Hospital
Department of Respiratory Medicine, University of Tokyo
Maho Suzukawa
National Hospital Organization, Tokyo National Hospital
Nobuharu Ohshima
National Hospital Organization, Tokyo National Hospital
Hiroyuki Tashimo
National Hospital Organization, Tokyo National Hospital
Isao Asari
National Hospital Organization, Tokyo National Hospital
Hirotoshi Matsui
National Hospital Organization, Tokyo National Hospital
Nobuyuki Kobayashi
National Hospital Organization, Tokyo National Hospital
Shunsuke Shoji
National Hospital Organization, Tokyo National Hospital
Takahide Nagase
Department of Respiratory Medicine, University of Tokyo
Ken Ohta
National Hospital Organization, Tokyo National Hospital

JOURNAL FREE ACCESS

2018 Volume 67 Issue Supplement.1 Pages S41-S44

DOI https://doi.org/10.1016/j.alit.2018.03.006

Details

Corresponding author

Register with J-STAGE for free!